These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 16125378)

  • 1. Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX.
    Chiang N; Arita M; Serhan CN
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):163-77. PubMed ID: 16125378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel endogenous small molecules as the checkpoint controllers in inflammation and resolution: entrée for resoleomics.
    Serhan CN; Chiang N
    Rheum Dis Clin North Am; 2004 Feb; 30(1):69-95. PubMed ID: 15061569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution.
    Serhan CN
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):141-62. PubMed ID: 16005201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo.
    Chiang N; Serhan CN; Dahlén SE; Drazen JM; Hay DW; Rovati GE; Shimizu T; Yokomizo T; Brink C
    Pharmacol Rev; 2006 Sep; 58(3):463-87. PubMed ID: 16968948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoxins and aspirin-triggered lipoxins in neutrophil adhesion and signal transduction.
    Filep JG; Khreiss T; József L
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):257-62. PubMed ID: 15979865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid-derived mediators in endogenous anti-inflammation and resolution: lipoxins and aspirin-triggered 15-epi-lipoxins.
    Serhan CN; Chiang N
    ScientificWorldJournal; 2002 Jan; 2():169-204. PubMed ID: 12806051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and bioactions of novel stable mimetics of lipoxins and aspirin-triggered lipoxins.
    Petasis NA; Akritopoulou-Zanze I; Fokin VV; Bernasconi G; Keledjian R; Yang R; Uddin J; Nagulapalli KC; Serhan CN
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):301-21. PubMed ID: 16098719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel omega -- 3-derived local mediators in anti-inflammation and resolution.
    Serhan CN
    Pharmacol Ther; 2005 Jan; 105(1):7-21. PubMed ID: 15626453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoxins and aspirin-triggered 15-epi-lipoxins are endogenous components of antiinflammation: emergence of the counterregulatory side.
    Serhan CN
    Arch Immunol Ther Exp (Warsz); 2001; 49(3):177-88. PubMed ID: 11478391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel rat lipoxin A4 receptor that is conserved in structure and function.
    Chiang N; Takano T; Arita M; Watanabe S; Serhan CN
    Br J Pharmacol; 2003 May; 139(1):89-98. PubMed ID: 12746227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoxins: pro-resolution lipid mediators in intestinal inflammation.
    Goh J; Godson C; Brady HR; Macmathuna P
    Gastroenterology; 2003 Apr; 124(4):1043-54. PubMed ID: 12671901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoxin A4 inhibits acute edema in mice: implications for the anti-edematogenic mechanism induced by aspirin.
    Menezes-de-Lima O; Kassuya CA; Nascimento AF; Henriques Md; Calixto JB
    Prostaglandins Other Lipid Mediat; 2006 Sep; 80(3-4):123-35. PubMed ID: 16939877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoids co-interact with lipoxin A4 via lipoxin A4 receptor (ALX) up-regulation.
    Hashimoto A; Murakami Y; Kitasato H; Hayashi I; Endo H
    Biomed Pharmacother; 2007 Jan; 61(1):81-5. PubMed ID: 17184966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoxins and aspirin-triggered lipoxins in resolution of inflammation.
    Romano M; Cianci E; Simiele F; Recchiuti A
    Eur J Pharmacol; 2015 Aug; 760():49-63. PubMed ID: 25895638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver: the formation and actions of aspirin-triggered lipoxins.
    Clària J; Planagumà A
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):277-82. PubMed ID: 16006110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenesis and lipoxins.
    Fierro IM
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):271-5. PubMed ID: 15982864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoxin and synthetic lipoxin analogs: an overview of anti-inflammatory functions and new concepts in immunomodulation.
    Parkinson JF
    Inflamm Allergy Drug Targets; 2006 Apr; 5(2):91-106. PubMed ID: 16613568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues.
    Takano T; Clish CB; Gronert K; Petasis N; Serhan CN
    J Clin Invest; 1998 Feb; 101(4):819-26. PubMed ID: 9466977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lipoxins--new view on old mediators carrying potent anti-inflammatory action].
    Jarmakowska K; Kuna P
    Pol Merkur Lekarski; 2005 May; 18(107):491-5. PubMed ID: 16161940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin-triggered lipoxin A4 and lipoxin A4 up-regulate transcriptional corepressor NAB1 in human neutrophils.
    Qiu FH; Devchand PR; Wada K; Serhan CN
    FASEB J; 2001 Dec; 15(14):2736-8. PubMed ID: 11687510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.